H-TAFTIPSI-OH
Ref. 3D-PP46850
1mg | 202,00 € | ||
10mg | 234,00 € | ||
100mg | 412,00 € |
Informação sobre produto
- NH2-Thr-Ala-Phe-Thr-Ile-Pro-Ser-Ile-OH
Peptide H-TAFTIPSI-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TAFTIPSI-OH include the following: Multilayered defense in HLA-B51-Associated HIV viral control YH Zhang, YC Peng, HP Yan, K Xu, M Saito - The Journal of , 2011 - journals.aai.orghttps://journals.aai.org/jimmunol/article/187/2/684/38834 Distinct HIV-1 escape patterns selected by cytotoxic T cells with identical epitope specificity Y Yagita, N Kuse, K Kuroki, H Gatanaga - Journal of , 2013 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02572-12 Adaptation of HIV-1 to human leukocyte antigen class I Y Kawashima, K Pfafferott, J Frater , P Matthews - Nature, 2009 - nature.comhttps://www.nature.com/articles/nature07746 Strong Human Endogenous RSTCR Are - J. Virol, 2011 - academia.eduhttps://www.academia.edu/download/44498147/Strong_human_endogenous_retrovirus-speci20160406-12165-kymueq.pdf HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates RB Jones , KE Garrison , S Mujib - The Journal of , 2012 - Am Soc Clin Investighttps://www.jci.org/articles/30670 Longitudinal analysis of an HLA-B* 51-restricted epitope in integrase reveals immune escape in early HIV-1 infection N Yager, N Robinson, H Brown, P Flanagan , J Frater - AIDS, 2013 - journals.lww.comhttps://journals.lww.com/aidsonline/fulltext/2013/01280/longitudinal_analysis_of_an_hla_b_51_restricted.2.aspx Monitoring HIV-specific CD8+ T cell responses by intracellular cytokine production MR Betts , JP Casazza, RA Koup - Immunology Letters, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165247801002735 Putative Immunodominant Human Immunodeficiency Virus-Specific CD8+ T-Cell Responses Cannot Be Predicted by Major Histocompatibility Complex Class I MR Betts , JP Casazza, BA Patterson, S Waldrop - Journal of , 2000 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.74.19.9144-9151.2000 Nonstandard Peptide Binding Revealed by M Takiguchi, DI Stuart , EY Jones , K Maenaka - J , 2000 - researchgate.nethttps://www.researchgate.net/profile/David_Stuart4/publication/12346091_Nonstandard_Peptide_Binding_Revealed_by_Crystal_Structures_of_HLA-B5101_Complexed_with_HIV_Immunodominant_Epitopes/links/56d4296608ae2ea08cf8db44/Nonstandard-Peptide-Binding-Revealed-by-Crystal-Structures-of-HLA-B5101-Complexed-with-HIV-Immunodominant-Epitopes.pdf Cytotoxic T-lymphocyte responses to HIV-1 reverse transcriptase L Menendez-Arias , A MAS , E DOMINGO - Viral immunology, 1998 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/vim.1998.11.167 A high-throughput MALDI-TOF MS biochemical screen for small molecule inhibitors of the antigen aminopeptidase ERAP1 L Muller, AK Burton, CL Tayler, JE Rowedder - SLAS Discovery, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S247255522213707X Identification of cross-clade CTL epitopes in HIV-1 clade A/E-infected individuals by using the clade B overlapping peptides K Watanabe, H Murakoshi, Y Tamura, M Koyanagi - Microbes and , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1286457913001548 Nonstandard peptide binding revealed by crystal structures of HLA-B* 5101 complexed with HIV immunodominant epitopes K Maenaka, T Maenaka, H Tomiyama - The Journal of , 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/165/6/3260/69809 Immunologic pressure within class I-restricted cognate human immunodeficiency virus epitopes during highly active antiretroviral therapy JP Casazza, MR Betts , BJ Hill, JM Brenchley - Journal of , 2005 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.79.6.3653-3663.2005 Targeting the regulatory site of ER aminopeptidase 1 leads to the discovery of a natural product modulator of antigen presentation J Liddle, JP Hutchinson, S Kitchen - Journal of Medicinal , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.9b02123 Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface. DP wOOLEY, P KT, T RJ, P CC, B MA - Aids, 2000 - search.proquest.comhttps://search.proquest.com/openview/67df1d0818c025701edfd260f85c5c2c/1?pq-origsite=gscholar&cbl=32744 Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection D SenGupta, R Tandon , RGS Vieira - Journal of , 2011 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.00179-11 Molecular basis of a dominant T cell response to an HIV reverse transcriptase 8-mer epitope presented by the protective allele HLA-B* 51: 01 C Motozono, N Kuse, X Sun , PJ Rizkallah - The Journal of , 2014 - journals.aai.orghttps://journals.aai.org/jimmunol/article/192/7/3428/108297 15. Peptide Motif of HLA-B* 5101 and the Linkage To Behaca§et's Disease C LEMMEL, HG RAMMENSEE - Immunology of Beh's , 2003 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=gqMp1w-AbbUC&oi=fnd&pg=PA127&dq=(%22NH2-Thr-Ala-Phe-Thr-Ile-Pro-Ser-Ile-OH%22+OR+%22TAFTIPSI%22+OR+%22H-TAFTIPSI-OH%22)+AND+peptide&ots=rx0-3VNeb_&sig=W_MzoZqUvaGP98nqgJsfijUlb4U 15. Peptide Motif of HLA-B* 5101 and the Linkage To Behaca§et's Disease C LEMMEL, HG RAMMENSEE - Immunology of Beh's , 2003 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=gqMp1w-AbbUC&oi=fnd&pg=PA127&dq=(%22NH2-Thr-Ala-Phe-Thr-Ile-Pro-Ser-Ile-OH%22+OR+%22TAFTIPSI%22+OR+%22H-TAFTIPSI-OH%22)+AND+peptide&ots=rx0-3VNf4X&sig=3dlo0vqJL7aja692EU3FMp9uyVg TCR clonotypes: molecular determinants of T-cell efficacy against HIV A Lissina, LA Chakrabarti, M Takiguchi - Current opinion in virology, 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1879625716000201
Propriedades químicas
Consulta técnica sobre: 3D-PP46850 H-TAFTIPSI-OH
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.